FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
+12.57%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$1.28B
AUM Growth
+$1.28B
(+15%)
Cap. Flow
+$79.4M
Cap. Flow
% of AUM
6.22%
Top 10 Holdings %
Top 10 Hldgs %
52.86%
Holding
80
New
6
Increased
21
Reduced
22
Closed
1
Top Buys
| 1 |
BCYC
Bicycle Therapeutics
BCYC
|
$26.5M |
| 2 |
Zentalis Pharmaceuticals
ZNTL
|
$21.4M |
| 3 |
TELA Bio
TELA
|
$17.5M |
| 4 |
Ultragenyx Pharmaceutical
RARE
|
$16.3M |
| 5 |
Outset Medical
OM
|
$13.9M |
Top Sells
| 1 |
BLU
BELLUS Health Inc.
BLU
|
$21.7M |
| 2 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$15.8M |
| 3 |
Krystal Biotech
KRYS
|
$11.1M |
| 4 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$7.57M |
| 5 |
Keros Therapeutics
KROS
|
$7.12M |
Sector Composition
| 1 | Healthcare | 94.83% |
| 2 | Communication Services | 5.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RETA
1
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $146M | 11.45% | 1,432,208 -154,720 | -10% | -$15.8M |
|
2
Prothena Corp
PRTA
$441M
| $102M | 8.03% | 1,500,129 -11,039 | -0.7% | -$754K |
|
3
AtriCure
ATRC
$1.84B
| $72.1M | 5.65% | 1,461,635 +2,578 | +0.2% | +$127K |
|
|
MODN
4
DELISTED
MODEL N, INC.
MODN
| $66M | 5.17% | 1,865,525 +11,852 | +0.6% | +$419K |
|
5
SI-BONE Inc
SIBN
$719M
| $57.1M | 4.47% | 2,114,829 +617 | +0% | +$16.6K |
|
6
Alphatec Holdings
ATEC
$2.35B
| $53.4M | 4.19% | 2,971,877 +27,752 | +0.9% | +$499K |
|
|
KRTX
7
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $45.3M | 3.55% | 208,746 -34,929 | -14% | -$7.57M |
|
8
Orthofix Medical
OFIX
$592M
| $44.4M | 3.48% | 2,459,129 -191,842 | -7% | -$3.46M |
|
|
BCYC
9
Bicycle Therapeutics
BCYC
$511M
| $44.4M | 3.48% | 1,739,449 +1,040,121 | +149% | +$26.5M |
|
10
NeoGenomics
NEO
$1.13B
| $43.3M | 3.39% | 2,692,057 -6,901 | -0.3% | -$111K |
|
|
FNA
11
DELISTED
Paragon 28, Inc.
FNA
| $36.5M | 2.86% | 2,057,307 +19,368 | +1% | +$344K |
|
12
Pliant Therapeutics
PLRX
$101M
| $32.8M | 2.57% | 1,810,176 +384,822 | +27% | +$6.97M |
|
13
Health Catalyst
HCAT
$239M
| $31.8M | 2.49% | 2,540,959 +560,642 | +28% | +$7.01M |
|
14
Transmedics
TMDX
$3.92B
| $31.7M | 2.48% | 377,464 +39,552 | +12% | +$3.32M |
|
15
Crinetics Pharmaceuticals
CRNX
$2.92B
| $28.1M | 2.2% | 1,557,222 -61,903 | -4% | -$1.12M |
|
|
16
Ultragenyx Pharmaceutical
RARE
$2.89B
| $27.2M | 2.13% | 589,963 +354,186 | +150% | +$16.3M |
|
17
OptimizeRx
OPRX
$335M
| $26.7M | 2.1% | 1,871,799 +860,868 | +85% | +$12.3M |
|
|
PHLT
18
Performant Healthcare, Inc. Common Stock
PHLT
$603M
| $25M | 1.96% | 9,249,683 +1,038,984 | +13% | +$2.81M |
|
19
Omnicell
OMCL
$1.5B
| $23.7M | 1.86% | 321,664 -11,845 | -4% | -$873K |
|
|
20
Zentalis Pharmaceuticals
ZNTL
$122M
| $21.4M | 1.68% | +757,835 | New | +$21.4M |
|
21
Halozyme
HALO
$8.56B
| $21.1M | 1.65% | 584,248 -103,958 | -15% | -$3.75M |
|
22
KORU Medical Systems
KRMD
$195M
| $18.3M | 1.43% | 5,299,639 -891,678 | -14% | -$3.08M |
|
23
Axogen
AXGN
$743M
| $18M | 1.41% | 1,973,699 +32,603 | +2% | +$298K |
|
24
Tactile Systems Technology
TCMD
$297M
| $17.7M | 1.39% | 711,345 +11,345 | +2% | +$283K |
|
|
25
TELA Bio
TELA
$70.5M
| $17.5M | 1.37% | +1,725,500 | New | +$17.5M |
|